Anthony P. Adamis - Jun 23, 2022 Form 3 Insider Report for EyePoint Pharmaceuticals, Inc. (EYPT)

Role
Director
Signature
Ron Honig, Attorney-in-Fact for Adamis Anthony P
Stock symbol
EYPT
Transactions as of
Jun 23, 2022
Transactions value $
$0
Form type
3
Date filed
6/27/2022, 04:37 PM
Next filing
Jun 22, 2023

No securities are beneficially owned.